Fostering dialogue and united actions in the field of rare diseases
The RDAF enables dialogue with key stakeholders in the field of rare diseases, including patients, physicians, the pharmaceutical industry, public authorities, and payors.
Multi-stakeholder workshops
Since 2015, the RDAF regularly organizes and moderates multi-stakeholder workshops in order to identify pathways for improvement and define action steps.
Value assessment for orphan drugs
Access to diagnosis
Registries for rare diseases
Access to diagnosis
Access to therapies
Reference centers and international cooperation
You can find the report from the RDAF most recent workshop here.
Other events
In March 2021, RDAF organized a webinar on rare diseases in Switzerland. Guest speakers included representatives from the pharmaceutical industry, healthcare professionals and experts on regulatory affairs. The report on the webinar can be found here.